Merck Capital Ventures Llc - Net Worth and Insider Trading
Merck Capital Ventures Llc Net Worth
The estimated net worth of Merck Capital Ventures Llc is at least $11 dollars as of 2024-05-16. Merck Capital Ventures Llc is the 10% Owner of HTG Molecular Diagnostics Inc and owns about 4,204 shares of HTG Molecular Diagnostics Inc (HTGMQ) stock worth over $11. Details can be seen in Merck Capital Ventures Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Merck Capital Ventures Llc has not made any transactions after 2015-05-11 and currently still holds the listed stock(s).
Transaction Summary of Merck Capital Ventures Llc
Merck Capital Ventures Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Merck Capital Ventures Llc owns 1 companies in total, including HTG Molecular Diagnostics Inc (HTGMQ) .
Click here to see the complete history of Merck Capital Ventures Llc’s form 4 insider trades.
Insider Ownership Summary of Merck Capital Ventures Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HTGMQ | HTG Molecular Diagnostics Inc | 2015-05-11 | 10 percent owner |
Merck Capital Ventures Llc Latest Holdings Summary
Merck Capital Ventures Llc currently owns a total of 1 stock. Merck Capital Ventures Llc owns 4,204 shares of HTG Molecular Diagnostics Inc (HTGMQ) as of May 11, 2015, with a value of $11.
Latest Holdings of Merck Capital Ventures Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HTGMQ | HTG Molecular Diagnostics Inc | 2015-05-11 | 4,204 | 0.00 | 11 |
Holding Weightings of Merck Capital Ventures Llc
Merck Capital Ventures Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Merck Capital Ventures Llc has made a total of 0 transactions in HTG Molecular Diagnostics Inc (HTGMQ) over the past 5 years. The most-recent trade in HTG Molecular Diagnostics Inc is the acquisition of 930 shares on May 11, 2015, which cost Merck Capital Ventures Llc around $2 Million.
Insider Trading History of Merck Capital Ventures Llc
- 1
Merck Capital Ventures Llc Trading Performance
GuruFocus tracks the stock performance after each of Merck Capital Ventures Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Merck Capital Ventures Llc is -49.8%. GuruFocus also compares Merck Capital Ventures Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Merck Capital Ventures Llc within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Merck Capital Ventures Llc's insider trading performs compared to the benchmark.
Performance of Merck Capital Ventures Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.03 | | | | | |
| Relative Return to S&P 500(%) | 3.86 | | | | | |
Merck Capital Ventures Llc Ownership Network
Merck Capital Ventures Llc Owned Company Details
What does HTG Molecular Diagnostics Inc do?
Who are the key executives at HTG Molecular Diagnostics Inc?
Merck Capital Ventures Llc is the 10 percent owner of HTG Molecular Diagnostics Inc. Other key executives at HTG Molecular Diagnostics Inc include Senior VP of Therapeutics Stephen Barat , 10 percent owner L5 Capital Inc. , and SVP/Chief Commercial Officer Byron Lawson .
HTG Molecular Diagnostics Inc (HTGMQ) Insider Trades Summary
Over the past 18 months, Merck Capital Ventures Llc made no insider transaction in HTG Molecular Diagnostics Inc (HTGMQ). Other recent insider transactions involving HTG Molecular Diagnostics Inc (HTGMQ) include a net sale of 888 shares made by Stephen Barat ,
In summary, during the past 3 months, insiders sold 0 shares of HTG Molecular Diagnostics Inc (HTGMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 888 shares of HTG Molecular Diagnostics Inc (HTGMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 888 shares.
HTG Molecular Diagnostics Inc (HTGMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
HTG Molecular Diagnostics Inc Insider Transactions
Merck Capital Ventures Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Merck Capital Ventures Llc. You might contact Merck Capital Ventures Llc via mailing address: One Merck Drive, Po Box 1000, Whitehouse Station Nj 08889.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
